Cargando…
mRNA vaccines against COVID‐19: a showcase for the importance of microbial biotechnology
Pfizer‐BioNTech and Moderna developed in record time mRNA vaccines against COVID‐19 of high efficacy. The modest protection achieved with a similarly designed mRNA from CureVac underlines the importance of biotechnological details in formulation such as replacement of uridine by pseudouridine in the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652446/ https://www.ncbi.nlm.nih.gov/pubmed/34788497 http://dx.doi.org/10.1111/1751-7915.13974 |